CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

bp-c1

Small moleculeexperimental

Clinical trial activity

6 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Jun 27, 2009 (NCT04298333)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • DNACROSS-LINKING AGENT

    DNA cross-linking agent

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • bp-c1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03627390Phase 2Dec 19, 2014Meabco A/S, Meddoc AS, Menoufia University, Norwegian University of Life Sciences
NCT03603197Phase 2Jun 5, 2014KhonKaen University, Meabco A/S, Meddoc AS, Norwegian University of Life Sciences
NCT01861509Phase 1Jun 1, 2013Meabco A/S
NCT03789019Phase 2Feb 22, 2013Meabco A/S, Meddoc AS, Norwegian University of Life Sciences
NCT02783794Phase 2Dec 1, 2012Meabco A/S, Meddoc AS, Norwegian University of Life Sciences
NCT04298333Phase 1Jun 27, 2009Meabco A/S, Meddoc AS, Norwegian University of Life Sciences
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Meabco A/SFor profit6622009
Meddoc ASAcademic/Hospital5022009
Norwegian University of Life SciencesAcademic/Hospital5022009
KhonKaen UniversityAcademic/Hospital1012014
Menoufia UniversityAcademic/Hospital1012014
5 organizations
Page 1 / 1